THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ: OPXA), a biotechnology company developing Tcelna® (imilecleucel-T), a novel T-cell immunotherapy for the treatment of multiple sclerosis (MS), today announced that Neil K. Warma, President and Chief Executive Officer, will present at two upcoming industry conferences. Details regarding these events are as follows:
Rodman & Renshaw 16th Annual Healthcare Conference
Help employers find you! Check out all the jobs and post your resume.
